Mithra Pharmaceuticals SA (MITRA.BR) Stock Price, Forecast & Analysis
Europe - Euronext Brussels - EBR:MITRA - BE0974283153 - Common Stock
MITRA.BR Key Statistics, Chart & Performance
The current stock price of MITRA.BR is 0.216 EUR. In the past month the price decreased by -20.15%. In the past year, price decreased by -92.45%.
MITRA.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 10.7 | 197.60B | ||
| 1SAN.MI | SANOFI | 10.69 | 197.40B | ||
| SAN.PA | SANOFI | 10.94 | 201.97B | ||
| MRK.DE | MERCK KGAA | 15.03 | 55.74B | ||
| UCB.BR | UCB SA | 39.09 | 48.81B | ||
| UNC.DE | UCB SA | 36.45 | 45.52B | ||
| BAYN.DE | BAYER AG-REG | 7.13 | 37.39B | ||
| 1BAYN.MI | BAYER AG-REG | 7.15 | 37.49B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.57 | 10.12B | ||
| IPN.PA | IPSEN | 11.72 | 10.09B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 108.41 | 10.04B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 21.2 | 8.94B |
Related stock screener links
About MITRA.BR
Company Profile
Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women’s health by offering new choices through innovation with a particular focus on contraception and menopause. The company is headquartered in Liege, Liege and currently employs 229 full-time employees. The company went IPO on 2015-06-30. The firm is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The firm provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The firm also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. The company offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The firm operates in more than 100 countries around the world and is headquartered in Liege, Belgium.
Company Info
Mithra Pharmaceuticals SA
Rue Saint-Georges 5
Liege LIEGE BE
Employees: 229
Phone: 3243492822
Mithra Pharmaceuticals SA / MITRA.BR FAQ
What does MITRA do?
Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women’s health by offering new choices through innovation with a particular focus on contraception and menopause. The company is headquartered in Liege, Liege and currently employs 229 full-time employees. The company went IPO on 2015-06-30. The firm is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The firm provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The firm also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. The company offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The firm operates in more than 100 countries around the world and is headquartered in Liege, Belgium.
Can you provide the latest stock price for Mithra Pharmaceuticals SA?
The current stock price of MITRA.BR is 0.216 EUR. The price decreased by -1.82% in the last trading session.
What is the dividend status of Mithra Pharmaceuticals SA?
MITRA.BR does not pay a dividend.
What is the ChartMill rating of Mithra Pharmaceuticals SA stock?
MITRA.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists MITRA stock?
MITRA.BR stock is listed on the Euronext Brussels exchange.
What is the Price/Earnings (PE) ratio of Mithra Pharmaceuticals SA (MITRA.BR)?
Mithra Pharmaceuticals SA (MITRA.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.42).
What is Mithra Pharmaceuticals SA worth?
Mithra Pharmaceuticals SA (MITRA.BR) has a market capitalization of 14.93M EUR. This makes MITRA.BR a Nano Cap stock.
MITRA.BR Technical Analysis
MITRA.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MITRA.BR. Both the profitability and financial health of MITRA.BR have multiple concerns.
MITRA.BR Financial Highlights
Over the last trailing twelve months MITRA.BR reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS increased by 32.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.04% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MITRA.BR Forecast & Estimates
9 analysts have analysed MITRA.BR and the average price target is 3.8 EUR. This implies a price increase of 1659.03% is expected in the next year compared to the current price of 0.216.
For the next year, analysts expect an EPS growth of 32.9% and a revenue growth 175.31% for MITRA.BR